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Background: Recruitment of patients with advanced cancer into studies is challenging. 
Objective: To evaluate recruitment methods in a study of pharmacist-led cancer pain medicines 
consultations and produce recommendations for future studies. 
Method: Two methods of recruitment were employed:  1) community-based (general practitioner 
computer search, identification by general practitioner, community pharmacist or district nurse and 
hospital outpatient list search), and 2) hospice-based (in and outpatient list search). Patients 
identified in method 1 were invited by post and in method 2 were invited face-to-face. Information 
was designed in collaboration with patients and carers. 
Results: 128 patients were identified (85 from the community and 43 from the hospice), 47 met the 
inclusion criteria. Twenty-three agreed to take part and 19 completed the study, 17 of whom were 
already under specialist palliative care. Recruitment rates were 7% for community-based methods 
and 40% for hospice. The recruitment methods differed in intensity of resource use. Recruitment via 
letter and a lack of engagement by healthcare professionals were found to be barriers. Facilitators 
included the researcher having personal involvement in recruitment. 
Conclusion: The overall recruitment rate was in line with other studies for this patient cohort. 
Attempts to identify and engage patients through community-based postal contact were less 
effective than where personal contact with patients was both possible and occurred. Methods were 
less successful at recruiting patients who were not already engaged with hospice services. 








Recruitment in health-services research is often challenging, especially when patients are seriously ill 
1-6. In such circumstances reported recruitment rates are 20% of the eligible population with 
numerous reasons suggested by authors for these rates 3, 4, 7-10. Studies that are unable to recruit to 
their planned sample size may fail to achieve research objectives and may be less generalizable 1. 
Time-pressures, due to the risk of rapid deterioration close to the end-of-life, may make recruitment 
and retention of participants particularly difficult 11. 
Gatekeeping is where either a healthcare professional or family member may decide on the patient’s 
behalf that they will not participate. It is often cited as a reason for low recruitment and is unethical 
as patient choice is taken away, skewing the sample towards subjects who are less ill 8, 9. The views 
of others are often considered by patients, making the family member’s or healthcare professional’s 
own views important12, 13. Patients with life-limiting health conditions may indeed need more care 
and empathy at the point of recruitment compared with the general population 14. Participation in 
research may be seen as a burden even if what is asked of the patient is kept to the minimum. 
However, healthcare professionals are sometimes surprised at the willingness of patients at the end-
of-life to take part in research 1. Many patients with serious health conditions such as terminal 
cancer feel altruistic in the hope they might be able to improve the experiences of healthcare for 
others after they die 1, 15, 16. 
The design of palliative care research may influence the patient’s decision whether to take part. 
Patients at the end-of-life are more likely to take part in simple rather than complex interventions 
and the more time and effort they need to participate in the research, the less likely patients are to 
consent 16, 17. Healthcare professionals are also known to favour less complex interventions and 
might therefore be more likely to refer patients into simple studies 18. To encourage participation, 




Researchers need to find methods that can identify suitable patients in complex and often 
disconnected healthcare systems. It is important for researchers to learn from the successes and 
failures of other studies so that future research can avoid pitfalls and improve efficiency and 
effectiveness of future recruitment in palliative care studies4.  
Aim 
To evaluate different recruitment methods used in the pharmacist-led IMPACCT study (Improving 
the Management of Pain from Advanced Cancer in the Community) 19. 
Objectives 
• To evaluate recruitment methods. 
• To identify individual barriers and facilitators to recruitment. 
• To produce recommendations for recruitment into future similar studies. 
 
Methods  
The wider IMPACCT study was approved by the National Health Service ethics committee (14-YH-
1126 141015) 19. Minor and substantial amendments were applied for when appropriate during the 
iterative development of the recruitment methods. 
 Patients were eligible to participate in the study if they fulfilled the following criteria:  
• Aged over 16 years old 
• Diagnosed with advanced cancer* 
• Aware of their diagnosis and experiencing pain associated with the cancer 
• Living in the community 
                                                          
* Patients with advanced cancer are defined as those with metastatic cancer with histological, cytological or 




• In receipt of a prescription for moderate or strong opioids† 
• Not prescribed anticipatory medicines‡ (therefore not in the last days of life) 
• Capacity to provide informed consent  
• Is a regular patient of one of the participating local community pharmacies. 
The consultation 
Patients were provided with one face-to-face consultation or two telephone medicines consultations 
from their usual community pharmacist or the Research Pharmacist (RP). All were accredited to 
provide these pharmacy services, however specific training was given to recruited pharmacists in 
pain and palliative care. Further details of the consultation content and findings are available 
elsewhere 20. 
Patient recruitment 
Patients were recruited between November 2015 and March 2017. Recruitment approaches were 
developed iteratively in response to recruitment rates. 
1. Community-based method  
Identification of patients 
Patients were identified using:  
i) searches of General Practitioner (GP)§ computer systems 
ii) healthcare professional referral  
                                                          
† Strong and moderate opioids are codeine, dihydrocodeine, hydrocodeine, tramadol, tapentadol, morphine, 
fentanyl, buprenorphine, diamorphine, hydromorphone, methadone and oxycodone. 
 
‡ Anticipatory medicines are those given in the last few days of life to manage pain and other symptoms. 
Often patients are prescribed these when this time is imminent and such patients would be too poorly to take 
part in the study. 
§ General Practitioners (GPs) or Family doctors) usually work in group practices within the UK and have read 





iv) hospital outpatient clinic list search.  
These methods were chosen as the consultations were to be delivered from local community 
pharmacies. Patient consent was not sought until they were deemed eligible and suitable for the 
study. 
i) searches of GP computer systems 
GP practices were considered for inclusion in the study if they had accreditation for research from 
the Royal College of General Practitioners and employed a practice pharmacist** (who routinely 
conducts electronic record searches). Eight out of ten practices approached took part. 
A data extraction tool was developed for the practice pharmacist to identify potentially suitable 
patients in the GPs’ clinical information system (TPP- SystmOne). The resulting list of patients was 
then manually checked against study inclusion criteria and a secure electronic message was sent to 
the doctor to approve the patient invitation.  
ii)  healthcare professional referral  
Local healthcare professionals (GP, district nurses and community pharmacists) were invited to 
presentations or individual meetings about the study to encourage participation and engagement. 
Pop-up messages were set up on GP computer systems to remind them when a patient was eligible. 
Eligibility was then checked using the patient record. Permission for district nurses to identify 
patients through their patient lists was secured from their local lead. Recruited community 
pharmacists were asked to identify potential patients and refer them to the practice pharmacist by 
telephone. Inclusion criteria was then checked, and approval was sought from the GP for invitation. 
 
                                                          





Community pharmacies were given posters to display and any interested patient would be referred 
to their practice pharmacist. No advertising was carried out in any other setting. 
iv) hospital outpatient clinic list search 
Due to low participation in the study, recruitment was extended to patients receiving care from 
hospital oncology outpatient clinics.  Research nurses (RNs), funded by the Clinical Research 
Network (CRN)21  searched patient clinic lists and then checked eligibility using the hospital’s 
information systems. In addition, the hospital outpatient pharmacy was asked to refer potential 
patients to the research nurses.  
Approach to the patient 
Patients were sent a participation information leaflet, consent form and accompanying letter by 
post. Surgery letters were signed by the practice pharmacist on behalf of the practice manager or 
the practice manager themselves. Hospital letters were signed by the RN. Those interested were 
invited to return the consent form to the University researchers and contact details were provided 
for any questions they might have about participating. All referrals and invitations were recorded on 
patient records to prevent anyone being invited more than once. Reasons for not inviting patients 









2. Hospice-based method 
Identification of patients  
Community-based recruitment was not yielding high enough participation so additional methods 
were developed. Hospice†† in-patients (admitted for symptom control), eligible for the study and 
ready to be discharged were identified by nursing staff.   
Patients were also identified in the outpatient day-unit by the nursing staff. 
Approach to the patient 
Both inpatient and outpatient approaches were made by nursing staff. Inpatients were then given 
participant information sheets and consent forms by the hospice Research Fellow (RF)‡‡.Outpatients 
were given participant information sheets and consent forms by the nursing staff. Patients were 
given the opportunity to discuss participation with their family and ask any questions they had. The 
RP conducting the study had regular presence on-site and was available for any queries.  Consent 
forms were then returned to the RP on-site. Reasons for not inviting patients who were identified 
were recorded. 
Sample size 
The IMPACCT study (which this recruitment was for) was a feasibility study. Therefore, no statistical 
analysis was planned, so a target for recruitment of 25 patients was set. This was considered a large 
enough sample size to assess acceptability and feasibility of the proposed intervention and 
opportunistic comparison of recruitment rates of the different methods.  
Data analysis 
                                                          
†† Hospice care in the UK now routinely involves patient attending for outpatient clinics or being admitted for 
short-term symptom control. 





The healthcare professionals involved were asked to record and report the numbers of patients 
identified and invited by email from the beginning of the study. Reasons for patients not being 
invited to take part were also recorded. From this, recruitment rates for each method were 
calculated.  
Successes and barriers for recruitment 
Healthcare professionals and patients were able to communicate perceived success factors and 
barriers with the researcher. A list of success factors and barriers was then produced by the researcher 
based on recruitment rates and problems encountered for each method. 
 
Results  
In total 128 patients were identified as being potentially eligible for the study, 47 were invited to take 
part, 23 were recruited and 19 completed (Figure 1). Reasons for not inviting patients following 





































Patients identified (n= 128) Excluded (n=71) 
• Patient not fulfilling 
inclusion criteria (n= 32) 
• Healthcare professionals 
didn’t act on or felt 
inappropriate to approach 
(n=7) 
• Already recruited by 
another method (n=4) 
• Patients not available to 
invite (n=10) 
• Patients deteriorated or 
died (n=12) 
• Data unavailable (n=13) 
• Declined to be approached 
(n=3) 
Total number of patients invited 
(n=47) 
Patients recruited (n=23) Patients 
withdrew/deteriorated/died 
(n=4) 
Patients completing the study 
(n=19) 
Patients identified from 
community-based recruitment 
n= 85 
Patients identified from 
hospice-based recruitment   
n= 43 





Table 1 shows how many patients were identified via each method. Anecdotally, practice pharmacists 
told us that monthly searches in each practice were not always possible. Not all healthcare 
professionals recorded details as requested and data was missing for a minority of patients. Numbers 
of patients referred from hospital outpatient searches are unknown although no patients were 
recruited following this method. No patients were referred by district nurses. All four hospice in-
patients who were recruited by the RF deteriorated and were unable to complete the study. 

















Searches of GP 
electronic 
system 
63 25 4 4 
GP referral and 
pop-up 
13 4 1 1 
District nurse 
referral 




1 0 0 0 
Community 
pharmacy poster 
 0 0 0 
Hospital 
research nurse 




 0 0 0 






5 4 4 0 
RP in hospice 38 13 13 13 
 Total 43 17 17 13 
 
Recruitment resulted in 2 patients who were not known to specialist palliative care services and 21 





Table 2  A recruitment breakdown showing patients identified and reasons patients were not 




Duration 16 months 5 months 
Patients identified 85 43 
Reasons for patients not being invited to participate 
Not currently in pain 3 5 
Pain not related to cancer 1 0 
Non-advanced disease 4 0 
Anticipatory medicines issued 5 0 
Nurse decided not appropriate 1 4 
Already recruited 3 1 
Did not use a participating 
pharmacy 
14 N/A 
Not available to approach N/A 10 
No follow-up by healthcare 
professional 
2 0 
Declined in person N/A 3 
Too unwell/deteriorated/died 9 3 
Data unavailable 13 0 
Invited to take part 30 17 
By letter 30 0 
Face-to-face 0 17 
Recruited 6 17 
Rate of identification to 
recruitment (%) 
7 40 
Died or withdrew before 
inclusion 
0 4 




Table 2 shows that recruitment from the community-based method took place over 16 months 
compared with 5 months in the hospice. Of a conservative estimate of 85 patients identified from the 
community-based method, 6 (7%) were recruited. Of 43 patients identified within the hospice, 17 
(40%) were recruited although only 13 (30%) completed the study. The total number of patients 
recruited was 23; of whom 19 completed the study. Reasons for loss of patients between identification 




Some patients within the hospice environment requested large print documentation and often 
required someone to read the study information to them due to its length and complexity. It is 
unclear whether this was also an issue in the community recruitment.  
The findings from the medicines consultations are reported elsewhere 20.  
Table 3 summarises the success factors and barriers for recruitment which were found in this study. 
Table 3 The success factors and barriers of recruitment methods of a palliative care study 
Component Reason for influence Success factor 
or barrier? 
   
Flexible approach to recruitment 
with willingness to adapt when 
required 
If recruitment is not working one way, 
strategies may need to be adapted 
according to the environment to achieve 
desired participant numbers. 
Success factor 
Face-to-face recruitment by 
knowledgeable staff with initial 
introductions from trusted sources 
Patient able to ask specific questions 
about the study and trusted source 
adding a form of endorsement. 
Success factor 
Research team having repeated 
presence in research environment 
Staff able to form relationships with 
research team whilst acting as a constant 
reminder and training aid for the study. 
Success factor 
   
Recruitment from in-patient 
population about to be discharged 
Patients tend to be nearer to death so 
increased deterioration and attrition. 
Barrier 
Lack of engagement of key 
personnel 
Clinicians, recruiters, practice pharmacists 
who are not engaged will be unlikely to ‘go 
the extra mile’ to recruit patients. 
Healthcare professionals may feel 
threatened by alternative service. 
Barrier 
Impersonal recruitment (letter) Letters and study documentation can be 
difficult to read and easy to ignore without 
context and someone to explain what 
might be involved. 
Barrier 
Gatekeeping Clinicians may feel protective of patients 
and prevent access. 
Barrier 
Lack of knowledge and experience 
of talking to patients at the end-of-
life 










By iteratively developing and extending recruitment methods, sufficient patients were recruited and 
the method which yielded the greatest number of participants was identified.  
 
As methods were developed iteratively, in response to recruitment rates, not all routes were available 
for the duration of the study. This makes any direct comparison between methods difficult. All 
methods used were complex, and whilst the hospice method of recruitment appeared to be most 
effective, we do not know whether this was due to the site and procedure of recruitment, the patients 
in hospice being a different subset of eligible patients or the face-to-face invitation. Not all personnel 
responsible for recruitment kept good records and communicated their findings to the researcher 
leading us to have some missing data. This was primarily healthcare professional identification 
numbers and reasons patients were not invited to take part from the practice pharmacists. This data 
would have made a more complete picture of recruitment. Also, our study design and ethical approval 
did not allow us to ask why patients did not want to take part and this information would have been 
useful when designing further studies. Future work will ensure this feedback is incorporated into the 
design as done in other studies 3, 4. 
 
The most effective method was hospice-based recruitment despite a loss due to deterioration, this 
may have been due to several factors. After the patient had been introduced to the study the hospice-
based method enabled them to easily talk to the RP if they had any questions before deciding whether 
to take part in the study. These questions were also able to be asked in the community-based method, 
but the RP was not as readily accessible, and patients would have needed to contact them via 
telephone. The comparative successes of recruitment within hospices has been found by other 




secondary care 2. The initial approach by hospice nurses may have resulted in higher recruitment due 
to their awareness of the needs and circumstances of individual patients 5, 22. The patient has an 
established relationship with hospice staff and sees the introduction to a study as a form of 
endorsement from a trusted source 1, 22. Patients may have felt less apprehensive about participation 
as they had already met the RP who would be performing the medicines consultation although this 
may have been the case if patients had been able to meet the RP from community-based recruitment 
although this may not have been logistically possible. Established rapport and trust with the 
researcher is often gained by their repeated presence in the research environment and can be 
beneficial to recruitment 22-24. Having study specific people at the point of recruitment to act as 
champions can be beneficial 10, 13. Both the hospice RF and the RP were highly motivated, and the 
hospice had made a commitment to research involvement more generally through their hosting of 
the RF. The benefits of the researcher’s personal role in the recruitment process has been found in 
other palliative care research and although this was feasible in this study where only a single hospice 
was involved, it may not be appropriate for a larger, multi-site study 4. 
Hospital recruitment had a very low recruitment rate although only a single hospital was involved. In 
contrast Stone et al found that hospital patients were more likely to consent to participate (once 
accessed) than patients from hospices and community settings although potential participants had 
direct access to the research team in this case and didn’t in the hospital in our study 2. The process of 
recruitment within the hospital was not a transparent one and communication with the team was 
more difficult than in the hospice setting. These problems with engagement and understanding of 
healthcare professionals involved in recruitment were not unique and resistance of some healthcare 
professionals to involvement in palliative care research has been found elsewhere. This may have 
been due to a lack of positive previous experience in research or concurrent studies competing for 




Several patients within the hospice wanted to ask family members what they thought before agreeing 
to take part and this may also have happened when recruiting by post 12, 13. This is a form of 
gatekeeping and future studies could produce family specific documentation for this purpose.  
Recruitment through primary care electronic record searches was found to be the least successful 
method although it did identify the highest number of patients for invitation. Research governance 
requires that only those directly involved in patient care have access to patient records and the study 
was thus reliant on the goodwill of practice pharmacists to allow time to carry out searches. The 
requirement for GP approval and perceived complexity of the process may have deterred community 
pharmacists and district nurses from referring patients due to time constraints. No patients were 
referred by district nurses possibly due to lack of engagement or large work volumes. Electronic pop-
ups in the GP clinical information system were not popular with healthcare professionals in this study 
but along with GP identification were responsible for the identification of 13 patients leading to one 
recruited. Pop-ups have been shown in other studies to have the potential to easily identify large 
numbers of suitable patients 26. 
Referral from community pharmacies or the hospital outpatient pharmacy resulted in only a small 
number of patients identified. This may have been due to concerns about potentially difficult 
conversations with patients with advanced cancer or lack of access to patient records, which has been 
found to be a barrier for community pharmacists talking to this patient group 27, 28.  
Recruitment both from primary and secondary care was done via letter and this was less successful 
than the personal contact used in hospice care. This may have been due to difficulties in reading the 
letter as was experienced in the hospice and elsewhere 29. 
Engagement of key personnel was found to be a barrier to recruitment (Table 3). Engagement was 




to form relationships with those staff. Asking healthcare professionals to help in research design (as 
was done in the hospice) was found to improve engagement and recruitment. 
Overall our recruitment rate was 23/128 (18%) and 19/128 (15%) completed the study. Attrition rates 
were low at 17% in contrast to a similar study but this may have been due to the short period of 
patient involvement in this study 30.  
Box 1 shows recommendations we have for future palliative care research based on our recruitment. 
Box 1 Recommendations for recruitment strategies for future palliative care studies  
Recommendations 
1. Involve key stakeholders in research from the earliest opportunity. This will allow not 
only engagement but also opportunity to influence research and make research methods 
as user (patient and healthcare professional) friendly as possible and will help to reduce 
gatekeeping. 
2. Concentrate recruitment for palliative care studies in hospices where possible. 
3. Recruit using trained and knowledgeable personnel via face-to-face methods with the 
opportunity for patients to ask questions where necessary. 
 
Conclusions 
We aimed to evaluate different recruitment methods for pharmacist-led cancer pain medicines 
consultations. Recruitment was most effective from the hospice outpatient population, but this did 
not allow the identification of patients who were not already receiving palliative care. Face-to-face 
methods of recruitment were more effective than postal methods and the presence of the research 




Early involvement of stakeholders such as healthcare professionals who may be involved in patient 
identification helps shape effective research and their engagement is key to success. 
A flexible approach to recruitment in palliative care research is essential and it is important to learn 
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